KABUL PROVINCE, Afghanistan – National Guard soldiers of the 226th Maneuver Enhancement Brigade from Mobile, Ala., received an anthrax vaccination today.
Many of the soldiers displayed their fear of needles and shots, while others questioned why they had to receive another anthrax vaccination.
According to the Army Anthrax Vaccine Immunization Program Plan (AVIP), “the mandatory scope of the AVIP shall encompass all personnel assigned to or deployed for more than 15 days in Higher Threat Areas (HTAs) defined in paragraph 3.a.(2) whose performance is essential for certain mission critical capabilities.”
In December of 2008, the Federal Drug Administration approved a five dose vaccination series in lieu of six. The injection will no longer be administered under the skin. The vaccination is now received in the upper deltoid region of the arm. Anthrax boosters are give, to soldiers who have completed the five series vaccination annually to maintain immunity.
All military service members, civilians, and DoD employees deploying to high risk areas are inoculated for the threat of anthrax.
“Anthrax is a disease of military importance. It can be weaponized and used with devastating effects. It is important for American soldiers to maintain a current valid anthrax immunization status,” says Col. John McGuinness, Task Force Tarpon Surgeon, 226th MEB.